title: Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat.
abstract: Rats with medial prefrontal cortex (mPFC) lesions are impaired in attentional set-shifting, when it is required to shift to a previously irrelevant perceptual dimension. The main source of noradrenergic input to the mPFC is from the locus coeruleus via the dorsal noradrenergic ascending bundle (DNAB). This study examined the effects of selective cortical noradrenaline depletion following 6-hydroxydopamine-induced lesions of the DNAB on attentional set-shifting and other aspects of discrimination learning and performance. Rats learned to dig in baited bowls, and then acquired discriminations based on one of two aspects of a bowl--odour or digging medium. The task tested acquisition of novel discriminations (both intra- and extra-dimensional) and reversal learning when contingencies were reversed with the same stimuli. At the conclusion of testing, the DNAB-lesioned rats were shown to have a selective depletion of noradrenaline of approximately 70% within the mPFC (cingulate and prelimbic cortex subregions), with no other significant changes in dopamine or 5-hydroxytryptamine. Rats required more trials to learn new discriminations when attentional shifting was required [extra-dimensional (ED)-shift]. Rats with dorsal noradrenergic ascending bundle (DNAB) lesions were impaired in novel acquisitions when an ED-shift was required, but were unimpaired in reversal learning and other aspects of discrimination learning, relative to controls. These data are consistent with other evidence implicating noradrenaline (NA) in attentional set-shifting, and contrast with effects of manipulations of 5-hydroxytryptamine (5-HT) and acetylcholine within the medial prefrontal cortex (mPFC). The findings are also relevant to recent theorizing about the functions of the coeruleo-cortical noradrenergic system.
authors.affiliation: School of Psychology, University of St Andrews, St Mary's College, South Street, St Andrews, Fife KY16 9JP, UK.
authors.forename: David S
authors.initials: DS
authors.lastname: Tait
authors.forename: Verity J
authors.initials: VJ
authors.lastname: Brown
authors.forename: Anja
authors.initials: A
authors.lastname: Farovik
authors.forename: David E
authors.initials: DE
authors.lastname: Theobald
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Dalley
authors.forename: Trevor W
authors.initials: TW
authors.lastname: Robbins
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001245:Association Learning / Q000187:drug effects / Q000502:physiology; D001288:Attention / Q000187:drug effects / Q000502:physiology*; D001522:Behavior, Animal / Q000187:drug effects; D001930:Brain Injuries / Q000139:chemically induced / Q000473:pathology*; D004193:Discrimination Learning / Q000187:drug effects / Q000502:physiology; D008297:Male; D008474:Medial Forebrain Bundle / Q000293:injuries / Q000378:metabolism* / Q000502:physiology*; D009638:Norepinephrine / Q000378:metabolism*; D016627:Oxidopamine; D011597:Psychomotor Performance / Q000187:drug effects; D051381:Rats; D012718:Set, Psychology; D013268:Stimulation, Chemical
chemical_list: D016627:Oxidopamine; D009638:Norepinephrine